WIF1 and lung carcinoma: Previous study has also indicated that TP derivative MRx102 upregulated WIF1 in lung cancer cell lines through decreasing methylation at the WIF1 promoter and increasing the unmethylated population in both A549 and H460 cells, exhibiting the inhibitory effect on the WNT pathway.